BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1706442)

  • 1. Pregnancy hormone levels signal trisomy 21, improved screening, lower costs possible.
    Randall T
    JAMA; 1991 Apr; 265(14):1797-8. PubMed ID: 1706442
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical screening tests for Down syndrome.
    Coetzee E; Viljoen D
    S Afr Med J; 1995 Feb; 85(2):72-3. PubMed ID: 7541163
    [No Abstract]   [Full Text] [Related]  

  • 3. Antenatal screening for Down's syndrome: where are we and where next?
    Haddow JE
    Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis of trisomy 21].
    Massé J; Forest JC
    Ann Biol Clin (Paris); 1990; 48(8):536-40. PubMed ID: 1705107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels.
    Cuckle HS; Wald NJ; Densem JW; Royston P; Knight GJ; Haddow JE; Palomaki GE
    Br J Obstet Gynaecol; 1990 Mar; 97(3):272-4. PubMed ID: 1692234
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving methods of screening for Down's syndrome.
    White I; Papiha SS; Magnay D
    N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple marker screening.
    Dickerson VM
    West J Med; 1994 Aug; 161(2):161. PubMed ID: 7524245
    [No Abstract]   [Full Text] [Related]  

  • 9. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gravidity and parity on the parameters used in serum screening for trisomy 21.
    Zimmermann R; Streicher A; Huch R; Huch A
    Prenat Diagn; 1995 Aug; 15(8):781-2. PubMed ID: 7479601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Triple screening for trisomy 21: prospective results of 7039 assessments].
    Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
    Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
    [No Abstract]   [Full Text] [Related]  

  • 12. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seeking other disorders within antenatal serum screening programmes for Down's syndrome.
    Wald NJ; Canick JA
    J Med Screen; 2002; 9(4):145-6. PubMed ID: 12518002
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor pregnancy outcome associated with elevated maternal serum alpha-fetoprotein in combination with increased risk for Down syndrome.
    Walters CP
    Prenat Diagn; 1993 Mar; 13(3):221-2. PubMed ID: 7685090
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
    Summers AM; Huang T; Wyatt PR
    Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.